Concepedia

Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study

Shigeto Ueda, Hitoshi Tsuda, Toshiaki Saeki, Jiro Omata, Akihiko Osaki, Takashi Shigekawa, Jiro Ishida, Katsumi Tamura, Yoshiyuki Abe, Tomoyuki Moriya,

Breast Cancer · 2010 · 42 citations · 27 references

DOI

Concepts

References

27

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations

, , +16

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

Helen Young, R. Baum, U. Cremerius et al. · European Journal of Cancer · 1999 · 1.7K citations · Full text

, , +16

Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial

Ian E. Smith, Mitch Dowsett, S. Ebbs et al. · Journal of Clinical Oncology · 2005 · 772 citations · Full text

, , +17

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Lalitha Shankar, John M. Hoffman, S.L. Bacharach et al. · PubMed · 2006 · 679 citations

, , +17

Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer

Mitch Dowsett, Ian E. Smith, S. Ebbs et al. · JNCI Journal of the National Cancer Institute · 2007 · 666 citations · Full text

, , +17